Apretude
基本信息
-
商品名Apretude
-
产品编号EMEA/H/C/005756
-
通用名cabotegravir
-
活性成分Cabotegravir
-
中文名称卡替拉韦
-
治疗领域HIV Infections
-
ATC代码J05AJ04
-
上市许可持有人ViiV Healthcare B.V.
-
批准时间2023-09-15
-
版本
-
孤儿药no
-
仿制药no
-
生物类似药no
-
加速评审no
-
附加条件批准no
-
特殊评审no
-
额外监管no
-
适应症Apretude is indicated in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in high-risk adults and adolescents, weighing at least 35 kg (see sections 4.2, 4.4 and 5.1).